Biomea Fusion, Inc. (BMEA) vs Neumora Therapeutics, Inc. Common Stock (NMRA)
A side-by-side comparison of Biomea Fusion, Inc. and Neumora Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.28HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
NMRA
Neumora Therapeutics, Inc. Common Stock
$0.48HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — BMEA vs NMRA
growth of $100 · dividends reinvested · last 3yBMEA -91.0% (-55.1%/yr)NMRA -96.8% (-68.1%/yr)BMEA compounded faster over this window
BMEA NMRA
BMEA vs NMRA: by the numbers
- •BMEA is the larger company ($92M vs $89M market cap).
Metrics side by side
Valuation
| Metric | BMEA | NMRA |
|---|---|---|
| P/B ratio | 7.60 | 2.01 |
Profitability
| Metric | BMEA | NMRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -268.09% | -477.87% |
| ROIC | -220.02% | -216.05% |
Growth (annualized)
| Metric | BMEA | NMRA |
|---|---|---|
| Total return CAGR (5Y) | -36.56% | N/A |
Go deeper
Dig into the metrics
Biomea Fusion ROENeumora Therapeutics, Inc. Common Stock ROEBiomea Fusion operating marginNeumora Therapeutics, Inc. Common Stock operating marginBiomea Fusion revenue growthNeumora Therapeutics, Inc. Common Stock revenue growthBiomea Fusion free cash flowNeumora Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.